Primer probe, kit and method for identifying Lactobacillus paracasei
The development of primers and probes based on SEQ ID NO.1 or SEQ ID NO.2 addresses the challenge of identifying Lactobacillus paracasei, providing a rapid and accurate method for its detection in complex environments, suitable for diverse applications.
Patent Information
- Application Number
- CN202310061419.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-01-17
- Publication Date
- 2024-12-06
- Estimated Expiration
- 2043-01-17
AI Technical Summary
There is a lack of a rapid, accurate, and effective method for identifying Lactobacillus paracasei, which hinders its widespread application in various fields.
The development of primers and probes based on the nucleotide sequence SEQ ID NO.1 or SEQ ID NO.2, specifically designed to identify Lactobacillus paracasei, along with a kit and method for genomic DNA extraction and PCR amplification, enabling specific and stable identification.
The primers and probes demonstrate high specificity, sensitivity, and stability in identifying Lactobacillus paracasei, suitable for complex environments and applications in production, daily life, and pharmaceuticals.
Smart Images

Figure CN116121422B_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the field of biotechnology, and more specifically to primers, probes, kits, and methods for identifying Lactobacillus paracasei. Background Technology
[0002] Due to their advantages such as short growth cycles and ease of strain modification, the development and utilization of microbial resources is a current research hotspot. Lactic acid bacteria are a class of microorganisms that utilize fermentable sugars to produce large amounts of lactic acid. They are diverse, widely distributed in nature, and the vast majority are safe and harmless to humans and animals, possessing health and medical benefits. They also improve food flavor, enhance nutritional value, and have antibacterial and preservative effects, making them popular among researchers both domestically and internationally. In recent years, the application of lactic acid bacteria in food, light industry, medicine, and feed has increased significantly. New types of lactic acid fermented foods and beverages, lactic acid bacteria preservatives, lactic acid bacteria preparations, lactic acid bacteria probiotics, and lactic acid bacteria feed additives are emerging in large numbers. While improving people's quality of life and promoting health, they have also created enormous economic benefits. Statistics show that the economic value created by the food industry using Lactobacillus as a fermentation starter alone accounts for 20% of the global fermented food market. Therefore, lactic acid bacteria, as the most important industrial microorganism, holds an irreplaceable priority for research and development.
[0003] *Lactobacillus paracasei*, belonging to the genus *Lactobacillus*, is widely found in fermented foods such as cheese and kimchi, as well as in the human mouth and intestines. A few reports also indicate that this strain can be isolated from some alcoholic beverages, such as low-alcohol sake and brandy. In recent years, extensive research has been conducted on the qualitative, screening, metabolic, and physiological aspects of *Lactobacillus paracasei*. A wealth of data suggests that *Lactobacillus paracasei* is suitable for a wide range of applications and has broad market prospects in production, daily life, and pharmaceuticals. However, a rapid, accurate, and effective identification method for *Lactobacillus paracasei* is still lacking. Summary of the Invention
[0004] The main objective of this invention is to provide primers, probes, kits, and methods for identifying *Lactobacillus paracasei*. This invention has screened and obtained a gene fragment that can specifically identify *Lactobacillus paracasei*, as shown in SEQ ID NO.1. The primers, probes, and kits described in this invention demonstrate high specificity and stability in identifying *Lactobacillus paracasei*.
[0005] To achieve the above objectives, the present invention adopts the following technical solution:
[0006] The first aspect of this invention provides the application of the nucleotide sequence shown in SEQ ID NO.1 or SEQ ID NO.2 in the identification of Lactobacillus paracasei. The nucleotide sequence shown in SEQ ID NO.2 is a partial sequence shown in SEQ ID NO.1.
[0007] A second aspect of the present invention provides primer probes for identifying Lactobacillus paracasei, said primer probes being designed based on the nucleotide sequence shown in SEQ ID NO.1 or SEQ ID NO.2.
[0008] Furthermore, the primer probe comprises the following primer pairs:
[0009] 1145-SF: 5'-GCAGGATGCTGATTGTTAGCAG-3';
[0010] 1145-SR: 5'-CTCCGACCAAAGCGACTATGAC-3.
[0011] A third aspect of the present invention provides a kit for identifying Lactobacillus paracasei, the kit comprising the primers and probes described below:
[0012] The primers and probes can amplify all or part of the nucleotide sequence shown in SEQ ID NO.1 or SEQ ID NO.2.
[0013] The fourth aspect of this invention provides a method for identifying Lactobacillus paracasei, the method comprising the following steps: extracting genomic DNA from a sample to be tested; using the extracted genomic DNA as a template, performing PCR amplification using primers and probes designed according to the nucleotide sequence shown in SEQ ID NO. 1 or SEQ ID NO. 2; and performing agarose gel electrophoresis on the amplification product; wherein the primers and probes are capable of amplifying all or part of the nucleotide sequence shown in SEQ ID NO. 1 or SEQ ID NO. 2.
[0014] Compared with the prior art, the present invention has the following advantages:
[0015] This invention has identified a gene fragment, as shown in SEQ ID NO.1, that can specifically identify *Lactobacillus paracasei*. The sequence of this gene fragment has been uploaded to the GenBank database, with the accession number OP681785. Primers and probes designed using the sequence shown in SEQ ID NO.1 as a template can rapidly and accurately identify *Lactobacillus paracasei*. The primers and probes described in this invention exhibit high specificity, high sensitivity, and high stability.
[0016] The primers, probes, reagent kits, and methods described in this invention are applicable to the identification of Lactobacillus paracasei in relatively complex environments. These primers, probes, and reagent kits have broad market prospects in production, daily life, and pharmaceutical and healthcare applications. Attached Figure Description
[0017] Figure 1 Image of 1145-S and 1145-S gene fragments on 0.8% agarose gel electrophoresis:
[0018] M: 2K plus II DNA marker; 1 in Figure a: 1145-S gene fragment; 1145-Ba fragment in Figure b;
[0019] Figure 2 Genomic DNA of Lactobacillus paracasei HP-B1145 was extracted using the CHELEX method and alkaline lysis method, and 16S rRNA gene amplification was performed.
[0020] M: 2KplusⅡDNAmarker; 1 shows the result of 16S rRNA gene amplification using HP-B1145 genomic DNA extracted by alkaline lysis method; 2 shows the result of 16S rRNA gene amplification using HP-B1145 genomic DNA extracted by CHELEX method.
[0021] Figure 3 Primer and probe design verification: Agarose gel electrophoresis image. Using Lactobacillus paracasei HP-B1145 genomic DNA as a template, primer and probe design was verified using 0.8% agarose gel electrophoresis.
[0022] M: 2KplusⅡ DNA marker; Figure a, 1: Validation using 1145-SF / 1145-SR primers and Lactobacillus paracasei HP-B1145 genomic DNA as a template. Figure b, 1: Validation using 1145-BaF / 1145-BaR primers and Lactobacillus paracasei HP-B1145 genomic DNA as a template.
[0023] Figure 4 Agarose gel electrophoresis image for primer and probe specificity testing. Genomic DNA of *Lactobacillus paracasei* HP-B1145 and genomic DNA from seven other strains were used as templates for primer and probe specificity testing.
[0024] M: 2KplusⅡ DNA marker; Figures 1-9: all use 1145-SF / 1145-SR as primers, and the selected templates are the genomic DNA of Lactobacillus paracasei HP-B1145, Pediococcus lactis, Lactobacillus plantarum, Lactobacillus acidophilus, Lactobacillus rhamnosus, Lactobacillus pentosus, Bifidobacterium animalis, Lactobacillus casei, and Escherichia coli.
[0025] Figure 5 Primers and probes can detect the content limits of genomic DNA. Agarose gel electrophoresis image. Genomic DNA content of *Lactobacillus paracasei* HP-B1145 was 100% (absolute content 900 ng / mL). -1 ), 70% (absolute content 975 ng·mL) -1 ), 30% (absolute content 270 ng·mL) -1 0% (absolute content 0 ng / mL) -1 Using the mixed DNA solution as a template, the content limit test of genomic DNA detectable by primer probes was performed, and the verification was carried out by 0.8% agarose gel electrophoresis.
[0026] M: 2KplusⅡ DNA marker; Figures 1-5: all used 1145-SF / 1145-SR as primers, with Lactobacillus paracasei HP-B1145 genomic DNA content of 100% (absolute content 900 ng·mL). -1 ), 70% (absolute content 975 ng·mL) -1 ), 30% (absolute content 270 ng·mL)-1 0% (absolute content 0 ng / mL) -1 A mixed DNA solution.
[0027] Figure 6 Primer and probe universality test: Agarose gel electrophoresis image. Primer and probe universality was tested using genomic DNA from *Lactobacillus paracasei* HP-B1145 and its closely related strains as templates.
[0028] M: 2KplusⅡ DNA marker; Figures 1-8: all used 1145-SF / 1145-SR as primers, and the selected templates were Lactobacillus paracasei HP-B1145, Lactobacillus paracaseiTMPC 46M17, Lactobacillus paracasei CD-M-1, Lactobacillus paracasei BCRC-16100, Lactobacillus paracasei AK508, and Lactobacillus paracasei KPP377 genomic DNA, respectively.
[0029] Figure 7 Agarose gel electrophoresis image of commercially available products containing *Lactobacillus paracasei* in their advertised formulations, using 1145-SF / 1145-SR primers and probes. M: 2K plus II DNA marker; in the image, lanes 1-3 all use 1145-SF / 1145-SR primers and probes. The template used in lane 1 is *Lactobacillus paracasei* HP-B1145, and lanes 2 and 3 represent commercially available products containing *Lactobacillus paracasei* in their advertised formulations. Detailed Implementation
[0030] It should be noted that the following detailed descriptions are exemplary and intended to provide further illustration of the invention. Unless otherwise specified, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention pertains.
[0031] It should be noted that the terminology used herein is for the purpose of describing particular embodiments only and is not intended to limit the exemplary embodiments of the present invention. As used herein, unless the context clearly indicates otherwise, the singular form is also intended to include the plural form. Furthermore, it should be understood that when the terms "comprising" or "including" are used in this specification, they indicate the presence of features, steps, operations, and combinations thereof.
[0032] To address the problems described in the background art, the first aspect of the present invention provides the application of the nucleotide sequence shown in SEQ ID NO.1 or SEQ ID NO.2 in the identification of Lactobacillus paracasei.
[0033] In a second aspect, the present invention provides primer probes for identifying Lactobacillus paracasei, said primer probes being designed based on the nucleotide sequence shown in SEQ ID NO.1 or SEQ ID NO.2.
[0034] In a preferred embodiment of the present invention, the primer probe is capable of amplifying all or part of the nucleotide sequence shown in SEQ ID NO.1 or SEQ ID NO.2.
[0035] In a preferred embodiment of the present invention, the primer probe includes the following primer pairs:
[0036] 1145-SF: 5'-GCAGGATGCTGATTGTTAGCAG-3';
[0037] 1145-SR: 5'-CTCCGACCAAAGCGACTATGAC-3.
[0038] A third aspect of the present invention provides a kit for identifying Lactobacillus paracasei, the kit comprising the primers and probes described below:
[0039] The primers and probes can amplify all or part of the nucleotide sequence shown in SEQ ID NO.1 or SEQ ID NO.2.
[0040] In a preferred embodiment of the present invention, the kit includes the following primers and probes:
[0041] 1145-SF: 5'-GCAGGATGCTGATTGTTAGCAG-3';
[0042] 1145-SR: 5'-CTCCGACCAAAGCGACTATGAC-3.
[0043] In a preferred embodiment of the present invention, the kit further includes genome extraction reagents and PCR amplification reagents.
[0044] The genome extraction reagents include alkaline lysis buffer I, lysozyme, RNase A enzyme, lysis buffer II, lysis buffer III, phenol, chloroform, isoamyl alcohol, and anhydrous ethanol; alkaline lysis buffer I consists of 50 mmol / L... -1Glucose, 25 mmol / L -1 pH 8.0 Tris-Cl, 10 mmol L -1 The solution consists of pH 8.0 EDTA; lysis buffer II consists of 0.2 mol / L... -1 The solution consisted of NaOH and 1% SDS (by mass); lysis buffer III consisted of 2 mol / L... -1 Potassium acetate and 2 mol L -1 Composition of glacial acetic acid.
[0045] The fourth aspect of this invention provides a method for identifying Lactobacillus paracasei, the method comprising the following steps: extracting genomic DNA from a sample to be tested; using the extracted genomic DNA as a template, performing PCR amplification using primers and probes designed according to the nucleotide sequence shown in SEQ ID NO. 1 or SEQ ID NO. 2; and performing agarose gel electrophoresis on the amplification product; wherein the primers and probes are capable of amplifying all or part of the nucleotide sequence shown in SEQ ID NO. 1 or SEQ ID NO. 2.
[0046] As a preferred embodiment of the present invention, the method for extracting genomic DNA from the sample to be tested is as follows: collect bacterial cells from the sample to be tested, add 100 μL of alkaline lysis buffer I, lysozyme and RNase A enzyme sequentially to the collected bacterial cells, and shake well; add alkaline lysis buffer II, mix well, and place on ice; after ice bath, add alkaline lysis buffer III, mix well, place on ice, centrifuge, take the supernatant, add phenol, chloroform and isoamyl alcohol, mix well, centrifuge, take the supernatant, add anhydrous ethanol, mix well; let stand, centrifuge, and dry; add ethanol solution, mix well, centrifuge, and dry the precipitate; resuspend in a solution containing 1×TE RNase A enzyme to obtain the final product;
[0047] In a preferred embodiment of the present invention, the alkaline lysis buffer I consists of 50 mmol / L -1 The lysis buffer II consisted of glucose, 25 mmol L⁻¹ pH 8.0 Tris-Cl, and 10 mmol L⁻¹ pH 8.0 EDTA; lysis buffer II consisted of 0.2 mol L⁻¹ Tris-Cl. -1 The solution consisted of NaOH and 1% SDS (by mass); lysis buffer III consisted of 2 mol / L... -1 Potassium acetate and 2 mol L -1 Composition of glacial acetic acid.
[0048] In a preferred embodiment of the present invention, the PCR reaction system is prepared with a genome concentration of 210 μg·L⁻¹. -1 The primer concentration is 21 μmol·L⁻¹ -1 Mg 2+ The concentration is 1.50 mmol·L. -1 .
[0049] The PCR reaction conditions were as follows: pre-denaturation: 92-99℃, 8-15 min; denaturation: 93-100℃, 1-4 min; annealing: 42-50℃, 30-60 s; extension: 68-78℃, 3-5 min; 30-35 cycles; final extension: 68-78℃, 10 min; storage: 12-17℃; the obtained PCR products were verified by 0.8% agarose gel electrophoresis.
[0050] To enable those skilled in the art to better understand the technical solution of the present invention, the technical solution of the present invention will be described in detail below with reference to specific embodiments.
[0051] Example 1
[0052] In previous studies, two specific bands were obtained, namely the nucleotide sequences shown in SEQ ID NO.1 (named 1145-S) and SEQ ID NO.3 (named 1145-Ba), and their agarose gel electrophoresis images are shown below. Figure 1 As shown; 1145-S is 848 bp in size, and 1145-Ba is 1716 bp in size. Using 1145-S and 1145-Ba as templates, specific primers were designed according to primer design principles using PrimerPremier 5 and Oligo 7 software, respectively. The specific primers and probes designed for the two fragments are as follows:
[0053] (1) Primers and probes designed using 1145-S as a template:
[0054] 1145-SF: 5'-GCAGGATGCTGATTGTTAGCAG-3';
[0055] 1145-SR: 5'-CTCCGACCAAAGCGACTATGAC-3'.
[0056] (2) Primers and probes designed using 1145-Ba as a template:
[0057] 1145-BaF: 5'-CTCATCATCACCAATCCATGAGCAC-3';
[0058] 1145-BaR: 5'-GCAGGATGCTGATTGTTAGCAG-3'.
[0059] The primers were synthesized by Genewiz, and subsequent experiments were conducted using the designed primers. SnapGene analysis showed that the designed primers could amplify fragments of *Lactobacillus paracasei* HP-B1145 with lengths of 489 bp (nucleotide sequence shown in SEQ ID NO.2) and 789 bp (nucleotide sequence shown in SEQ ID NO.4).
[0060] Using Lactobacillus paracasei HP-B1145 genomic DNA as a template, PCR reactions were performed using 1145-SF / 1145-SR primers and probes and 1145-BaF / 1145-BaR primers and probes, respectively, with 2×Taq MasterMix (Dye Plus) as the Taq enzyme.
[0061] Genomic DNA extraction using alkaline lysis method:
[0062] Lactobacillus paracasei HP-B1145 was cultured on MRS solid medium for 24 h, and a portion of the cells was transferred to a 1.5 ml EP tube. 100 μL of alkaline lysis buffer I (50 mmol / L glucose, 25 mmol / L pH 8.0 Tris-Cl, 10 mmol / L pH 8.0 EDTA) and lysozyme (50 mg / mL) were added sequentially. -1 ) and RNase A enzyme (10 mg / L), 900 rpm·min -1 Shake for 1 min. Add 200 μL of alkaline lysis buffer II (0.2 mol / L NaOH solution, 1% SDS). Alkaline lysis buffer II must be prepared fresh for use. Invert the container 5 times to ensure thorough mixing. Incubate on ice for 30 min. Add 160 μL of pre-cooled alkaline lysis buffer III (5 mol / L), 60.0 mL of potassium acetate, 11.5 mL of glacial acetic acid, and 28.5 mL of sterile ultrapure water. Invert the container 5 times. Incubate on ice for 5 min, then thaw at 12000 rpm·min. -1 Centrifuge for 5 min. Take 460 μL of the supernatant, add an equal volume of phenol / chloroform / isoamyl alcohol, mix well, and centrifuge at 12000 rpm·min. -1 Centrifuge for 5 min, collect 460 μL of the supernatant, add 2 volumes of ice-cold anhydrous ethanol, mix well, and allow DNA to precipitate at room temperature for 10 min, then centrifuge at 12000 rpm·min. -1 Centrifuge for 5 min and dry the precipitate at 37°C. Add 1 mL of 70% ethanol, mix by inverting, centrifuge again, and dry the precipitate. Resuspend in 50 μL of 1×TE solution containing RNase A (10 mg / L) and store at -20°C for later use.
[0063] Genomic DNA was extracted using the CHELEX method: A small amount of Lactobacillus paracasei HP-B1145 cells were picked and mixed with a sterile CHELEX-100 gel, lysed at 95°C for 15 minutes, and the supernatant was collected to obtain the genomic DNA of HP-B1145.
[0064] Genomic DNA extracted using the alkaline lysis method and the CHELEX method was used for 16S rRNA gene amplification, and the results are as follows: Figure 2 As shown, genomic DNA extracted by alkaline lysis is more advantageous as a PCR template.
[0065] The PCR reaction system involved is as follows: pre-denaturation 92-99℃, 8-15 min; denaturation 93-100℃, 1-4 min; annealing 42-50℃, 30 s-1 min; extension 68-78℃, 3-5 min; 30-35 cycles; final extension 68-78℃, 10 min; storage 12-17℃.
[0066] Template concentration was 210 μg·L -1 The primer concentration was 21 μmol·L⁻¹ -1 Mg 2+ The concentration is 1.50 mmol·L. -1 Unless otherwise specified, the template concentration for all PCR reactions described below is 210 μg·L⁻¹. -1 The primer concentrations were all 21 μmol·L⁻¹ -1 Mg 2 + The concentration was 1.50 mmol·L⁻¹. -1 .
[0067] The obtained PCR products were verified by 0.8% agarose gel electrophoresis, and the results are as follows: Figure 3 As shown, the target band can be effectively amplified using 1145-SF / 1145-SR primers and probes.
[0068] Specificity test of 1145-SF / 1145-SR primers and probes
[0069] *Pediococcus lactis*, *Lactobacillus plantarum*, *Lactobacillus acidophilus*, *Lactobacillus rhamnosus*, *Lactobacillus pentosus*, *Bifidobacterium animalis*, *Lactobacillus casei*, and *Escherichia coli* were used as controls for primer and probe specificity testing. PCR was performed on the above strains and *Lactobacillus paracasei* HP-B1145 using the 1145-SF / 1145-SR primers and probes. The PCR reaction system involved was as follows: pre-denaturation (92-99℃, 8-15 min); denaturation (93-100℃, 1-4 min); annealing (42-50℃, 30 s-1 min); extension (68-78℃, 3-5 min); cycling (30-35 cycles); final extension (68-78℃, 10 min); storage (12-17℃). The obtained PCR products were verified by 0.8% agarose gel electrophoresis. The results are shown below. Figure 4 As shown, the 1145-SF / 1145-SR primer-probe combination exhibits good specificity.
[0070] The 1145-SF / 1145-SR primer probe can be used for limit testing of genomic DNA content.
[0071] A mixture of *Pediococcus lactis*, *Lactobacillus plantarum*, *Lactobacillus acidophilus*, *Lactobacillus rhamnosus*, *Lactobacillus pentosus*, *Bifidobacterium animalis*, *Lactobacillus casei*, *Escherichia coli*, and *Lactobacillus paracasei* HP-B1145 was prepared, with each strain containing 100% (absolute content 900 ng / mL). -1 ), 70% (absolute content 975 ng·mL) -1 ), 30% (absolute content 270 ng·mL) -1 0% (absolute content 0 ng / mL) -1 Using a mixed DNA solution as a template, and employing 1145-SF / 1145-SR primers and probes, a PCR reaction was performed with 2×Taq Master Mix (Dye Plus) as the Taq enzyme.
[0072] The PCR reaction system involved was as follows: pre-denaturation 92-99℃, 8-15 min; denaturation 93-100℃, 1-4 min; annealing 42-50℃, 30-60 s; extension 68-78℃, 3-5 min; 30-35 cycles; final extension 68-78℃, 10 min; storage 12-17℃. The obtained PCR products were verified by 0.8% agarose gel electrophoresis, and the results are as follows: Figure 5 As shown, the primer probe has good sensitivity.
[0073] Universality test of 1145-SF / 1145-SR primers and probes
[0074] Five strains of *Lactobacillus paracasei*—TMPC 46M17, CD-M-1, BCRC-16100, AK508, and KPP3777—were used as controls for primer and probe universality testing. PCR was performed on these strains and *Lactobacillus paracasei* HP-B1145, using primers 1145-SF / 1145-SR. The PCR reaction system was as follows: pre-denaturation 92-99℃, 8-15 min; denaturation 93-100℃, 1-4 min; annealing 42-50℃, 30-60 s; extension 68-78℃, 3-5 min; 30-35 cycles; final extension 68-78℃, 10 min; storage 12-17℃. The obtained PCR products were verified by 0.8% agarose gel electrophoresis, and the results are as follows: Figure 6 As shown, the primer probes 1145-SF / 1145-SR have good universality in identifying Lactobacillus paracasei.
[0075] Using 1145-SF / 1145-SR primers and probes to identify commercially available products containing Lactobacillus paracasei in their listed formulations.
[0076] Three commercially available products containing *Lactobacillus paracasei* were selected. Genomic DNA was extracted from these products and used as templates for PCR reactions using 1145-SF / 1145-SR primers and probes. The PCR reaction system was as follows: pre-denaturation 92-99℃, 8-15 min; denaturation 93-100℃, 1-4 min; annealing 42-50℃, 30-60 s; extension 68-78℃, 3-5 min; 30-35 cycles; final extension 68-78℃, 10 min; storage 12-17℃. The obtained PCR products were verified by 0.8% agarose gel electrophoresis. The results are shown below. Figure 7 As shown.
[0077] Example 2
[0078] A kit for identifying Lactobacillus paracasei, the kit comprising the primers and probes described below:
[0079] 1145-SF: 5'-GCAGGATGCTGATTGTTAGCAG-3';
[0080] 1145-SR: 5'-CTCCGACCAAAGCGACTATGAC-3'.
[0081] The kit also includes genome extraction reagents and PCR amplification reagents; the genome extraction reagents include alkaline lysis buffer I, lysozyme, RNase A enzyme, lysis buffer II, lysis buffer III, phenol, chloroform, isoamyl alcohol, and anhydrous ethanol; alkaline lysis buffer I is prepared from 50 mmol / L... -1 The lysis buffer II consisted of glucose, 25 mmol L⁻¹ pH 8.0 Tris-Cl, and 10 mmol L⁻¹ pH 8.0 EDTA; lysis buffer II consisted of 0.2 mol L⁻¹ Tris-Cl. -1 The solution consisted of NaOH and 1% SDS (by mass); lysis buffer III consisted of 2 mol / L... -1 Potassium acetate and 2 mol L -1 Composition of glacial acetic acid.
[0082] The reagents also include 2×Taq Master Mix (Dye Plus), Mg 2+ Solution and water.
[0083] Example 3
[0084] A method for identifying Lactobacillus paracasei, the method comprising the following steps:
[0085] Genomic DNA was extracted from the sample using an alkaline lysis method. Using the extracted genomic DNA as a template, PCR amplification was performed using primers and probes designed based on the nucleotide sequence shown in SEQ ID NO.1. The amplification products were then subjected to agarose gel electrophoresis.
[0086] The primer probe:
[0087] 1145-SF: 5'-GCAGGATGCTGATTGTTAGCAG-3';
[0088] 1145-SR: 5'-CTCCGACCAAAGCGACTATGAC-3'.
[0089] The method for extracting genomic DNA from the sample is as follows: Collect bacterial cells from the sample, add 100 μL of alkaline lysis buffer I, lysozyme, and RNase A enzyme sequentially to the collected bacterial cells, and shake well; add alkaline lysis buffer II, mix well, and incubate on ice; after incubation on ice, add alkaline lysis buffer III, mix well, incubate on ice again, centrifuge, collect the supernatant, add phenol, chloroform, and isoamyl alcohol, mix well, centrifuge again, collect the supernatant, add anhydrous ethanol, mix well; let stand, centrifuge, and dry; add ethanol solution, mix well, centrifuge, and dry the precipitate; resuspend in 1×TE solution containing RNase A enzyme to obtain the final product;
[0090] The alkaline lysis buffer I consists of 50 mmol / L -1 The lysis buffer II consisted of glucose, 25 mmol L⁻¹ pH 8.0 Tris-Cl, and 10 mmol L⁻¹ pH 8.0 EDTA; lysis buffer II consisted of 0.2 mol L⁻¹ Tris-Cl. -1 The solution consisted of NaOH and 1% SDS (by mass); lysis buffer III consisted of 2 mol / L... -1 Potassium acetate and 2 mol L -1 Composition of glacial acetic acid.
[0091] The PCR reaction system was prepared with a genome concentration of 210 μg·L⁻¹. -1 The primer concentration is 21 μmol·L⁻¹ -1 Mg 2+ The concentration is 1.50 mmol·L. -1 ;
[0092] The PCR reaction conditions were as follows: pre-denaturation: 92-99℃, 8-15 min; denaturation: 93-100℃, 1-4 min; annealing: 40-45℃, 30 s-1 min; extension: 68-78℃, 2-4 min; 30-35 cycles; final extension: 68-78℃, 10 min; storage: 12-17℃; the obtained PCR products were verified by 0.8% agarose gel electrophoresis.
[0093] The above embodiments are preferred embodiments of the present invention, but the embodiments of the present invention are not limited to the above embodiments. Any changes, modifications, substitutions, combinations, or simplifications made without departing from the spirit and principle of the present invention shall be considered equivalent substitutions and shall be included within the protection scope of the present invention.
Claims
1. Application of the nucleotide sequence shown in SEQ ID NO.1 or SEQ ID NO.2 in identifying Lactobacillus paracasei.
2. A method for identifying Lactobacillus paracasei for non-disease diagnosis purposes, characterized in that, The method comprises the following steps: extracting genomic DNA of a sample to be tested; using the extracted genomic DNA as a template, and using a primer probe designed according to the nucleotide sequence shown in SEQ ID NO.1 or SEQ ID NO.2 to perform PCR amplification; and performing agarose gel electrophoresis on the amplified product to obtain the product; the primer probe can amplify all or part of the nucleotide sequence shown in SEQ ID NO.1 or SEQ ID NO.2; The primer probe includes the following primer pairs: 1145-SF: 5'-GCAGGATGCTGATTGTTAGCAG-3'; 1145-SR: 5'-CTCCGACCAAAGCGACTATGAC-3.
3. The method according to claim 2, characterized in that: The method for extracting genomic DNA of the sample to be tested is as follows: collect bacteria in the sample to be tested, add 100 μL of alkaline lysis solution I, lysozyme and RNase A enzyme to the collected bacteria in sequence, and shake well; add alkaline lysis solution II, mix well, and place in an ice bath; add alkaline lysis solution III after ice bath, mix well, and place in an ice bath, centrifuge to obtain supernatant, add phenol, chloroform and isoamyl alcohol, mix well, centrifuge to obtain supernatant, add anhydrous ethanol, and mix well; let stand, centrifuge, and dry; Add ethanol solution, mix well, centrifuge, dry the precipitate, and resuspend it with 1×TE solution containing RNase A enzyme.
4. The method according to claim 3, characterized in that: The alkaline lysis solution I is composed of 50 mmol L -1 Glucose, 25mmolL -1 pH 8.0 Tris-Cl, 10 mmol L -1 pH 8.0 EDTA; Lysis buffer II consists of 0.2 mol L -1 NaOH solution, 1% SDS; Lysis solution III consists of 2 mol L -1 Potassium acetate and 2 mol L -1 Composition of glacial acetic acid.
5. The method according to claim 2, characterized in that: In the PCR reaction system, the genome concentration was 210 μg·L -1 , the primer concentration was 21 μmol·L -1 ,Mg 2+ Concentration: 1.50mmol·L -1 ; PCR reaction conditions were as follows: initial denaturation: 92-99°C, 8-15 min; Denaturation: 93-100°C, 1-4 min; Annealing: 42-50℃, 30-60s; Extension: 68-78℃, 3-5min; 30-35 cycles; Final extension: 68-78℃, 10min; Storage: 12-17°C; verify the PCR product by 0.8% agarose gel electrophoresis.
Citation Information
Patent Citations
A method for specific detection of Lactobacillus acidophilus
CN109423524A
Specific primers for amplifying lactobacillus paracasei and application of specific primers
CN111286550A
Molecular marker, detection primer and detection method used for identifying lactobacillus casei class group
CN112029884A
Specific primers and kit for rapidly identifying lactobacillus paracasei, and application
CN113981115A
Methods for discriminating interspecific relationships and intraspecific relationships of lactic acid bacteria of lactobacillus casei group
US20170058327A1
